Sponsored SymposiaStructural heart disease

SOLACI-CACI 2021 | Current Controversies in Post-TAVR CORONARY ACCESS – Medtronic Symposium

solaci
solaci
521
0

✔️ MEDTRONIC Symposium in the SOLACI-CACI 2021 Virtual Congress.
✔️ Topic: Current Controversies in Post-TAVR CORONARY ACCESS.

👨‍🏫 Program:

  • 00:07 – Opening – Fabrio Brito.
  • 03:03 – Resolving Coronary Access after TAVR Implantation – Oscar Millan.
  • 18:20 – Deferred Access. Acute Coronary Syndrome I in a TAVR Patient – Henrique Ribeiro.
  • 39:44 – Acute Coronary Syndrome II in a TAVR Patient – Matías Sztejfman.
  • 51:41 – Discussion: The Role of Commissural Alignment Selecting a Guidewire Tips & Tricks.
  • 57:43 – Final Comments and Closing – Fabio Brito.

👉 Moderator: Dr. Fabio Brito.
👉 Panelists: Dr. Carla Agatiello – Dr. Fabio Brito- Dr. Pablo Charry – Dr. Luis Gutiérrez – Dr. Oscar Millán – Dr. Henrique Ribeiro – Dr. Matías Sztejfman.

This event took place on August 5th, 2021.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
SOLACI-CACI 2021 | Current CONTROVERSIES in INTERVENTIONAL CARDIOLOGY – Medtronic Symposium
Next article
SOLACI-CACI 2021 | Leading with Evidence, Choosing With Confidence – MICROPORT Symposium
solaci
solaci

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Dr. Omar Tupayachi - 0
The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Dr. Juan Manuel Pérez - 0
Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Dr. Juan Manuel Pérez - 0
Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Structural heart disease

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the...
Dr. Juan Manuel Pérez -
SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Dr. Andrés Rodríguez - 0
Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Dr. Omar Tupayachi - 0
The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...